Gilead Sciences
Search results
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 13th Largest Pharma Company in India, In terms of Domestic Sales for MAT September 2023
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
3 days ago · Get all the information on Emcure Pharmace with historic price charts for NSE / BSE. Experts & Broker view also get the Emcure Pharmace Ltd. buy/sell tips detailed news, announcements,...
3 days ago · Emcure Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Emcure Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Success Through Innovation | Emcure Pharmaceuticals Ltd. (EPL) is an Indian pharmaceutical company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad...
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
Get the latest Emcure Pharmaceuticals Ltd (EMCURE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Emcure Pharmaceuticals is a fast-growing Indian pharmaceutical company engaged in developing, manufacturing & marketing a broad range of pharmaceutical products globally.
Emcure Pharma's IPO saw strong investor interest, with oversubscription rates of 67.87 times. Post-listing, shares rose 4.5% to Rs. 1384, reflecting confidence in the company's future.
